Question · Q4 2025
Michael Mueller asked for more color on Ventas's decision to exclude non-cash compensation from Normalized FFO going forward and the G&A expense embedded in the 2026 guidance.
Answer
Robert F. Probst, EVP and CFO, clarified that the exclusion of non-cash stock-based compensation (8 cents in both 2025 and 2026) aims to align with market practices for healthcare REITs, making earnings more comparable. He stated that cash G&A for 2026 is expected to be in the low $150 million range, growing in line with the enterprise's expansion.
Ask follow-up questions
Fintool can predict
VTR's earnings beat/miss a week before the call


